Technology
Health
Medical

iRadimed

$25.59
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.04 (0.16%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell iRadimed and other stocks, options, ETFs, and crypto commission-free!

About

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices and accessories and services. It also provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for use during MRI procedures. Read More The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

Employees
95
Headquarters
Winter Springs, Florida
Founded
1992
Market Cap
280.77M
Price-Earnings Ratio
49.55
Dividend Yield
0.00
Average Volume
80.34K
High Today
$26.46
Low Today
$25.00
Open Price
$25.66
Volume
95.89K
52 Week High
$38.78
52 Week Low
$13.75

Collections

Technology
Health
Medical
Advertising and Marketing
Medical Devices
Business Services
2014 IPO
US

News

MarketBeatMar 8

Stock Price, News, & Analysis for Iradimed

Media stories about IRMD stock have trended somewhat positive this week, InfoTrie reports. The research firm scores the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Iradimed earned a media sentiment score of 1.4 on InfoTrie's scale. They also assigned news coverage about the medical equipment provider a news buzz of 5.0 out of 10, meaning...

4
Simply Wall StMar 8

One Thing To Remember About The IRadimed Corporation (NASDAQ:IRMD) Share Price

If you’re interested in IRadimed Corporation (NASDAQ:IRMD), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your portfolio.

2
Guru FocusMar 7

iRadimed Corp (IRMD) Files 10-K for the Fiscal Year Ended on December 31, 2018

iRadimed Corp (NASDAQ:IRMD) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. iRadimed Corp develops, manufactures, markets and distributes Magnetic Resonance Imaging compatible products to acute care facilities and outpatient imaging centers, both in the United States and internationally.

2

Earnings

$0.01
$0.06
$0.11
$0.16
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Apr 30, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.